Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; Arauz, G.; Curley, T.; Tse, K.; Halabi, S.; Scher, H. I.; Kelly, W. K.
Abstract Title:	Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
Meeting Title:	52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	15 Suppl.
Meeting Dates:	2016 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-05-20
Start Page:	289s
Language:	English
ACCESSION:	WOS:000404711501069
DOI:	10.1200/JCO.2016.34.15_suppl.TPS5093
PROVIDER:	wos
Notes:	Meeting Abstract: TPS5093 -- Source: Wos